We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Feather Safety Razor

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Mortality Rates Lower at Major Teaching Hospitals

By HospiMedica International staff writers
Posted on 05 Jun 2017
Print article
Image: The Harvard School of Public Health (Photo courtesy of Wikimedia).
Image: The Harvard School of Public Health (Photo courtesy of Wikimedia).
Admission to an academic medical center (AMC) is associated with a lower overall 30-day risk of death compared with admission to a non-teaching hospital, according to a new study.

Researchers at Harvard School of Public Health (HSPH; Boston, MA, USA), Massachusetts General Hospital (MGH; Boston, USA), and other institutions conducted a study using U.S. national Medicare data to compare mortality rates in teaching and non-teaching hospitals for common medical and surgical conditions among beneficiaries 65 years and older. The sample consisted of 21,451,824 total hospitalizations at 4,483 hospitals, of which 250 (5.6%) were major teaching, 894 (19.9%) were minor teaching, and 3,339 (74.3%) were non-teaching hospitals.

The main outcomes and measures were 30-day mortality rate for all hospitalizations and for 15 common medical and 6 surgical conditions. Secondary outcomes included 30-day mortality stratified by hospital size, and 7-day mortality and 90-day mortality for all hospitalizations, as well as for individual medical and surgical conditions. The results revealed that unadjusted 30-day mortality was 8.1% at major teaching hospitals, 9.2% at minor teaching hospitals, and 9.6% at non-teaching hospitals, representing a 1.5% mortality difference between major teaching hospitals and non-teaching hospitals.

After adjusting for patient and hospital characteristics, the same pattern persisted, but the difference in mortality between major and non-teaching hospitals was smaller. Further stratification by hospital size showed that 187 large (over 400 beds) AMCs had lower adjusted overall 30-day mortality (8.1%) relative to 76 large non-teaching hospitals (9.4%). The same pattern was observed in medium-sized hospitals. Among smaller hospitals, with less than 100 beds hospitals, minor teaching hospitals had lower overall 30-day mortality relative to non-teaching hospitals. The study was published on May 23, 2017, in JAMA.

“Academic medical centers provide a unique environment, with 24-hour availability of specialty services, advanced technologies, and some of the most expert physicians in the country. This seems to pay off for patients,” said lead author Laura Burke, MD, of HSPS. “While obviously not all patients can receive care in major teaching hospitals, understanding which strategies and resources are particularly important to patient outcomes, and how they can be replicated among nonteaching hospitals, is critically important to improve care for all patients.”

“We found to our surprise that across a wide range of medical and surgical conditions, patients at teaching hospitals did better; they were less likely to die,” added senior author Ashish Jha, MD, MPH, of HSPS. “While mortality may not be the only indicator that matters, it certainly is the most important one. We know that short term mortality is driven largely by how well the hospital does in taking care of patients.”

AMCs are often considered more expensive than community hospitals and some insurers have excluded them from their networks in an attempt to control costs, assuming that quality is comparable.

Related Links
Harvard School of Public Health
Massachusetts General Hospital

Print article


Critical Care

view channel
Image: EsoGuard has demonstrated over 90% specificity and 90% sensitivity in identifying Barrett’s Esophagus (Photo courtesy of Lucid Diagnostics)

Biomarker Based Non-Endoscopic Technology Identifies Risk for Esophageal Cancer

Barrett's esophagus (BE) is the benign and treatable precursor condition to esophageal adenocarcinomas (EAC) which is usually diagnosed at an advanced stage and is difficult to treat. Finding BE, a sign... Read more

Surgical Techniques

view channel
Image: Bio-glue enables near-instantaneous gelling, sealing and healing of injured tissue (Photo courtesy of Pexels)

Game-Changing ‘Bio-Glue’ Could End Use of Surgical Sutures and Staple

Tissue adhesive washout and detachment are major issues for medical practitioners and may prove fatal for patients, especially when the separation happens in vital organs like the lungs, liver and the heart.... Read more

Patient Care

view channel
Image: Future wearable health tech could measure gases released from skin (Photo courtesy of Pexels)

Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases

Most research on measuring human biomarkers, which are measures of a body’s health, rely on electrical signals to sense the chemicals excreted in sweat. But sensors that rely on perspiration often require... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.